The Motley Fool

Key Data Points

Primary metrics and data points about Celgene.
Current Price: $115.46
Prev Close: $118.08
Open: $114.62
Bid: $115.46
Ask: $115.70
Day's Range: $114.62 - $118.40
52wk Range: $83.16 - $140.72
Volume: 6,316,664
Avg Vol 5,036,617
Market Cap: $91B
P/E (ttm): 44.73
EPS (ttm): $2.64
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Celgene.

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

CELG vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Celgene.
CAPS Rating 5 out of 5
2024 Outperform
74 Underperform
CAPS All Stars
478 Outperform
13 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert J. Hugin, CEO

97% Approve

Based on 56 Ratings

More Details for CelgeneJobs

Powered by

More Details about Celgene

Primary metrics and data points about Celgene.